Filing Details
Perspective Therapeutics, Inc. (AMEX:CATX) filed a Form 8-K with the Securities and Exchange Commission on October 08, 2026, disclosing a material event.
8k filedAMEX:CATX
Perspective Therapeutics, Inc. (CATX) Reports Material Event to SEC
Perspective Therapeutics, Inc. (AMEX:CATX) filed a Form 8-K with the Securities and Exchange Commission on October 08, 2026, disclosing a material event.
At publication ·
What changed
Perspective Therapeutics, Inc. (AMEX:CATX) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Perspective Therapeutics (CATX) filed a Form 8-K on October 8, 2026 disclosing a material event to shareholders.
- The stock trades at $2.71 with a market capitalization of $200.3 million.
- Form 8-K filings report significant events such as leadership changes, material agreements, acquisitions, or asset sales.
Market Context
Perspective Therapeutics, Inc.'s stock currently trades at $2.71 with a market capitalization of $200.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Perspective Therapeutics, Inc.'s stock.
All SEC filings for Perspective Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CATX Stock Page
Frequently Asked Questions
Where can I read CATX's SEC filings?
Browse all filings on our CATX SEC filings page.
What types of SEC filings does Perspective Therapeutics, Inc. file?
Public companies like Perspective Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.